Document Detail

Cellular and molecular mechanisms of venous leg ulcers development--the "puzzle" theory.
MedLine Citation:
PMID:  20224526     Owner:  NLM     Status:  MEDLINE    
This review presents a hypothetical model of the development of a venous leg ulcer. The primary pathology is venous hypertension that leads to increased capillary permeability, resulting in extravasation of erythrocytes. Macrophages produce proinflammatory cytokines, which enhance the expression of adhesion molecules in the endothelium of postcapillary venules and increase the recruitment of leukocytes to the pericapillary interstitium. Extravasated T lymphocytes stimulated by cytokines, which are produced by activated macrophages, differentiate toward the Th1 phenotype. In the case of excessive extracapillary passage of erythrocytes or impaired transport of ferric ions by macrophages, the accumulation of iron in the dermis can occur. In tissues with a high concentration of iron, T lymphocytes proliferate instead of undergoing apoptosis. This is possible due to the internalization of the INF-gR2 chain of the interferon-g receptor, the downregulation of inducible nitric oxide synthase expression in macrophages and the inactivation of the active site of caspases. Stimulated by interferon-g skin keratinocytes produce chemokines: CXCL9, CXCL10 and CXCL11, which attract T lymphocytes. Finally, positive feedback loops develop resulting in the migration of T lymphocytes toward the epidermis and in high local concentrations of interferon-g and keratinocyte-derived chemokines. T lymphocytes invading epidermis produce interferon-g and Fas ligand. High concentrations of interferon-g result in the overexpression of Fas by keratinocytes. Matrix metalloproteinases shed Fas ligand from T lymphocytes. The combined effect of Fas ligand and interferon-g on Fas-overexpressing keratinocytes results in their abundant apoptosis and dermo-epidermal detachment, which is clinically manifested as blister-like lesions that progress to chronic ulcerations.
M Simka
Related Documents :
17239146 - Fas-mediated upregulation of vascular endothelial growth factor and monocyte chemoattra...
14681686 - Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glu...
20685386 - Differential effects of formaldehyde exposure on the cell influx and vascular permeabil...
15390286 - Interferon-gamma sensitizes osteosarcoma cells to fas-induced apoptosis by up-regulatin...
16907916 - Intracellular cytokine profile of t lymphocytes in patients with chronic obstructive pu...
11907276 - Activation and caspase-mediated inhibition of parp: a molecular switch between fibrobla...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International angiology : a journal of the International Union of Angiology     Volume:  29     ISSN:  1827-1839     ISO Abbreviation:  Int Angiol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-12     Completed Date:  2010-07-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8402693     Medline TA:  Int Angiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  1-19     Citation Subset:  IM    
Department of Angiology, Private Healthcare Institution SANA, Pszczyna, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Capillary Permeability*
Cytokines / immunology
Disease Progression
Endothelium, Vascular / immunology
Erythrocytes / immunology*,  metabolism,  pathology
Inflammation Mediators / immunology
Iron / metabolism
Keratinocytes / immunology,  pathology
Macrophages / immunology
Risk Factors
T-Lymphocytes / immunology*,  metabolism
Varicose Ulcer / etiology*,  immunology,  metabolism,  pathology,  physiopathology
Venous Pressure*
Reg. No./Substance:
0/Cytokines; 0/Inflammation Mediators; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The geriatric depression scale as a screening tool for depression and suicide ideation: a replicatio...
Next Document:  Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.